Optibrium Company

Optibrium provides elegant software solutions for small molecule design, optimisation and data analysis. The company’s lead product, StarDrop, is a comprehensive suite of integrated software with a highly visual and user-friendly interface. StarDrop enables a seamless flow from the latest data through to predictive modelling and decision-making regarding the next round of synthesis and research, improving the speed, efficiency, and productivity of the discovery process. Founded in 2009, Optibrium is headquartered in Cambridge, UK with offices in Boston, US. Optibrium continues to develop new products and research novel technologies to improve the efficiency and productivity of the drug discovery process. Optibrium works closely with its broad range of customers and collaborators that include leading global pharma, agrochemical and flavouring companies, biotech and academic groups.

Investors

Technology: Software
Industry: AI in Pharma, Early Drug Development
Headquarters: Cambridge, Cambridgeshire, United Kingdom
Founded Date: 2009-01-01
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 1
Total Funding: 1314135
Estimated Revenue: $10M to $50M
Last Funding Date: 2018-09-19
Last Funding Type: Grant

Visit Website
nfo@optibrium.com
https://twitter.com/Optibrium
Register and Claim Ownership